Intercellular adhesion molecule 1 (ICAM-1), a counter-receptor for lymphocyte function-associated antigen 1 on T cells, is critically important to a wide variety of adhesion-dependent leukocyte functons, including antigen presentation and target cell lysis. 
. The X ORF encodes a polypeptide of 16.5 kDa, which is designated as X protein (pX) . Expression of pX elicits an antibody (anti-pX) response in HBV-infected individuals (3) (4) (5) (6) . pX transactivates a variety of viral and human genes, including those of the human immunodeficiency virus and class I and II major histocompatibility complex (MHC) molecules (7) (8) (9) (10) (11) (12) (13) . Since class I and II MHC genes are involved in antigen-specific immune responses of T cells, their transactivation by pX suggests that HBV may directly participate in the immunologic response of the host to infected hepatocytes.
HBV infection results in several distinct outcomes: acute and chronic hepatitis, a chronic carrier state, and development of hepatocellular carcinoma (1, 2) . It is generally accepted that hepatocellular necrosis during HBV infection is the result of the host immune response against one or more HBV antigens expressed on the surface of infected hepatocytes (14) (15) (16) (17) (18) . Extensive studies indicate that cytotoxicity mediated by T cells is the principal mechanism (14) (15) (16) (17) (18) . The asymptomatic HBV carrier state appears to represent a state of clonal anergy in which the T cells remain functionally unresponsive to infected hepatocytes (13, 19, 20) . Following treatment and withdrawal of immunosuppressive medications or chemotherapeutic agents, chronic carriers may develop aggressive hepatitis (20) ical outcomes ranging from fulminant hepatitis to the asymptomatic carrier state remain undefined (14, 15) .
Recent evidence indicates that optimal interaction of TCR with antigen-MHC complexes requires concurrent binding of adhesion molecules on T cells with their counter-receptors on either antigen-presenting cells or target cells (21, 22) . Lymphocyte function-associated antigen 1 (LFA-1), an adhesion molecule of the integrin family, is expressed on T cells (21, 22) . LFA-1 binds to its counter-receptor, intercellular cell adhesion molecule 1 (ICAM-1), a cell surface glycoprotein that is a member of the immunoglobulin superfamily (21) (22) (23) (24) .
Binding of LFA-1 to ICAM-1 is critically important to a wide variety of adhesion-dependent leukocyte functions (24) (25) (26) . For example, antibody against ICAM-1 can block T-cell cytotoxicity, and cotransfection of fibroblasts with ICAM-1 and MHC class II cDNAs is required for activation of T-helper cells (27, 28) . Inflammatory cytokines, such as interferon y (IFN-y), interleukin 1, and tumor necrosis factor, induce ICAM-1 expression and potentiate the immune response (21, 22) .
Although normal hepatocytes do not express ICAM-1, expression by hepatocytes has been observed in inflamed biopsy specimens from patients with HBV infection (29) (30) (31) .
Whether ICAM-1 expression is induced indirectly by inflammatory cytokines (21, 22) Proc. Natl. Acad. Sci. USA 89 (1992) MATERIALS AND METHODS Plasmid Vectors. All HBV plasmid vectors used in this study were derived from a cloned HBV adw strain ( Fig. 1 ) (32). As previously described (13, 33) , pNER contains the entire HBV genomic DNA. The plasmid pUC13 was used to construct the following subgenomic HBV vectors: pUCSL (containing the OREs for pre-S/S and X) and pUCC (containing the ORFs for core/e and X) (13) . The plasmid vector pMNX (containing the X ORF alone) was a gift of Aleem Siddiqui (13) . Plasmid pICAM-1, kindly provided by Brian Seed, contains a 1.85-kb cDNA sequence of human ICAM-1 (24) .
Celi Lines and Transfection. HepG2, HuH-7, and Hep3B human hepatoma cell lines were used. HepG2 and HuH-7 are negative for HBV DNA, whereas Hep3B cells express and secrete hepatitis B surface antigen (HBsAg) (34, 35) . Cell culture and DNA transfection were performed as reported (13, 33) . Specifically, calcium phosphate precipitation was used for DNA transfection (13, 33 (38) . Nuclear run-on assays for ICAM-1 were performed in HepG2 and MNX cells as described (13, 33, 39) , except that 32P-labeled nuclear RNA was extracted by an acid phenol/guanidinium thiocyanate procedure (40) rather than trichloroacetic acid precipitation (39) . All hybridization signals were analyzed quantitatively with a computerized densitometer (Helena Laboratories).
RESULTS

HBV and ICAM-1 Protein Expression in HBV DNA-
Transfected Hepatoma Cells. Expression of HBV peptide antigens following transfection was verified in the culture medium and in cells by radioimmunoassay (RIA) and immunocytochemistry, respectively (13 (Fig. 3) .
Northern blots showed that HepG2 cells transfected with the HBV genome and MNX cells expressed two species of ICAM-1 RNA of approximately 3.2 kb and 1.9 kb (Fig. 4) To test whether enhanced expression ofICAM-1 RNA was due to a transcriptional or posttranscriptional mechanism, nuclear run-on assays were performed with nuclei from MNX augment the already enhanced expression ofICAM-1 RNA in MNX cells (Fig. 6) . DISCUSSION Extensive studies have indicated that HBV peptide antigens, such as pre-S/S and core/e, are expressed on the surface of hepatocytes during HBV infection and that membranous expression is associated with inflammatory infiltrates predominantly composed of T cells (16) (17) (18) . It is widely believed that the host immune response against HBV antigen(s) mediates hepatocellular necrosis, since HBV does not appear to be directly cytopathic in vitro or in the chronic HBV carrier state (14, 15) . Immunohistochemical studies of liver biopsy samples from patients with HBV infection and hepatocellular necrosis have demonstrated increased expression of class I MHC antigens and de novo expression of both class II MHC antigens (14, 15) and ICAM-1 (15, 30, 31) . In contrast, normal human hepatocytes express small amounts of class I MHC molecules, whereas class II MHC molecules and ICAM-1 are absent (15, 29) . Since inflammatory cytokines can induce in vitro synthesis of class I and II MHC molecules and ICAM-1 (15, 21, 22) , expression of these molecules in inflamed liver biopsy samples has been attributed to cytokines. Recent studies demonstrating that pX can transactivate both class I and II (12, 13) MHC genes in vitro has provided an alternative explanation.
Optimal interaction of CD4 and CD8 T cells with either antigen-presenting cells or target cells requires concurrent binding of T-cell antigen receptors to antigen-MHC complexes and binding of adhesion molecules to their counterreceptors (24) (25) (26) . Of particular importance is ICAM-1, which serves as a counter-receptor for LFA-1 expressed by mature T cells (21, 24) . Coexpression of ICAM-1 and class II MHC molecules is required to activate T-helper cells (28) . Moreover, not only does induction of ICAM-1 on target cells increase susceptibility to lysis by cytotoxic T cells, but lysis can be blocked by anti-ICAM-1 antibody (27) . Expression of ICAM-1 by HBV-infected cells, therefore, could play impor- tant roles in the immunopathogenesis of hepatocellular necrosis by altering either the afferent or the efferent components of the immune response. Thus, we used an in vitro expression system for HBV (13, 33) (45, 46) . pX has been shown to alter the DNA binding specificity of the CREB and ATF-2 transcription factors through protein-protein interaction (47) . Binding of pX to the large tumor antigen of simian virus 40 can prevent transactivation by pX (48) . Evidence that pX has protein kinase activity (49) and amino acid sequence homology to a seine protease inhibitor (50) (51, 52) . In contrast, pX transactivation appears to involve formation of intracellular pX-protein complexes capable of binding to specific gene response elements (47, 48) . As expected, optimal concentrations of recombinant human IFN-y (24) induced increased ICAM-1 RNA expression in both nontransfected HepG2 and HuH-7 cells. However, IFN-y did not augment the increased level of ICAM-1 RNA expression in MNX cells. There are two possible interpretations of these results. First, it is possible that transactivation of the ICAM-1 gene by pX was maximal and that IFN-y could not exert an additive effect. Second, pX might have inhibited the formation or function ofISGF3y, a phenomenon observed with adenovirus ElA protein (52) . Elucidation of the specific mechanism(s) of pX induction of ICAM-1 will be required to evaluate these possibilities.
In view of the putative immunopathogenesis of hepatocellular necrosis in HBV infection, pX transactivation of class I and II MHC molecules (12, 13) and ICAM-1 in hepatocytes could play an important role in the initiation of the host immune response to HBV infection. Experimentally, two signals appear to be necessary for clonal expansion and differentiation of functional T cells (19, 53) . The absence of a costimulatory second signal results in functional clonal inactivation or clonal anergy (19, 53 (20) . Further investigation is required to evaluate the potential role of pX transactivation of class II MHC and ICAM-1 genes in the initiation of the host immune response to HBV infection and the capacity of infected hepatocytes to provide a costimulatory second signal.
